H-type hypertension and C reactive protein in recurrence of ischemic stroke

International Journal of Environmental Research and Public Health

Volumn 13, Issue 5, 2016, Pages

  Zhang, Qing ^a   Qiu, De Xing ^b   Fu, Rong Li ^a   Xu, Tian Fen ^c   Jing, Meng Juan ^a   Zhang, Hui Shan ^c   Geng, He Hong ^a   Zheng, Long Chao ^d   Wang, Pei Xi ^a,c  

^a HENAN UNIVERSITY   (China)

^b Shenzhen guangming medical group guangming new district center hospital   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

^d GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; H type hypertension; Recurrence ischemic stroke

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

AGE STRUCTURE; AMINO ACID; DIABETES; DISEASE CONTROL; DISEASE INCIDENCE; GENDER IDENTITY; HEALTH GEOGRAPHY; HEALTH STATUS; HYPERTENSION; MULTIVARIATE ANALYSIS;

ADULT; AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD BIOCHEMISTRY; BRAIN ISCHEMIA; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; H TYPE HYPERTENSION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RECURRENCE RISK; RECURRENT DISEASE; RISK REDUCTION; SEX DIFFERENCE; TEACHING HOSPITAL; BLOOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; STROKE;

CHINA; HENAN;

BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CHINA; DIABETES MELLITUS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RECURRENCE; STROKE;

EID: 84966455365     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13050477     Document Type: Article

References (50)

1. Ministry of Health, People’s Republic of China. The main situation of the third National Death survey. Chin. J. Oncol. 2008, 17, 344–345.
2. Hardie, K.; Hankey, G.J.; Jamrozik, K.; Broadhurst, R.J.; Anderson, C. Ten-year risk of first recurrent stroke and disability after first ever stroke in the Perth Community stroke study. Stroke 2004, 35, 731–735. [CrossRef] [PubMed]
3. Leoo, T.; Lindgren, A.; Petersson, J.; von Arbin, M. Risk factors and treatment at recurrent stroke onset: Results from the Recurrent Stroke Quality and Epidemiology (RESQUE) Study. Cerebrovasc. Dis. 2008, 25, 254–260. [CrossRef] [PubMed]
4. Ueshima, H.; Choudhury, S.R.; Okayama, A.; Hayakawa, T.; Kita, Y.; Kadowaki, T.; Okamura, T.; Minowa, M.; Iimura, O. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA 80. Stroke 2004, 35, 1836–1841. [CrossRef] [PubMed]
5. Turan, T.N.; Cotsonis, G.; Lynn, M.J.; Chaturvedi, S.; Chimowitz, M.; Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007, 115, 2969–2975. [CrossRef] [PubMed]
6. Laloux, P.; Lemonnier, F.; Jamart, J. Risk factors and treatment of stroke at the time of recurrence. Acta Neurol. Belg. 2010, 110, 299–302. [PubMed]
7. Zhang, Y.; Huo, Y. Hypertension with Elevated Homocysteine—H-Type Hypertension. Adv. Cardiovasc. Dis. 2011, 32, 3–6.
8. Hu, D.; Xu, X. Prevention of stroke relies on valid control H-type hypertension. Chin. J. Intern. Med. 2008, 47, 976–977. (In Chinese)
9. Towfighi, A.; Markovic, D.; Ovbiagele, B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study. J. Neurol. Sci. 2010, 298, 153–157. [CrossRef] [PubMed]
10. Ridker, P.M. C-reactive protein: Eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin. Chem. 2009, 55, 209–215. [CrossRef] [PubMed]
11. Schillinger, M.; Exner, M.; Mlekusch, W.; Sabeti, S.; Amighi, J.; Nikowitsch, R.; Timmel, E.; Kickinger, B.; Minar, C.; Pones, M. et al. Inflammation and Carotid Artery—Risk for Atherosclerosis Study (ICARAS). Circulation 2005, 111, 2203–2209. [CrossRef] [PubMed]
12. Kotlęga, D.; Białecka, M.; Kurzawski, M.; Droździk, M.; Ciećwież, S.; Gołąb-Janowska, M.; Nowacki, P. Risk factors of stroke and -717A>G (rs2794521) CRP gene polymorphism among stroke patients in West Pomerania province of Poland. Neurol. Neurochir. Pol. 2014, 48, 30–34. [CrossRef] [PubMed]
13. The Neuroscience Society. All kinds of cerebrovascular disease diagnosis points. Chin. J. Neurol. 1996, 29, 379.
14. Morris, D.L.; Rosamond, W.; Madden, K.; Schultz, C.; Hamilton, S. Prehospital and emergency department delays after acute stroke: The Genentech Stroke Presentation Survey. Stroke 2000, 31, 2585–2590. [CrossRef] [PubMed]
15. Qin, X.; Huo, Y. H Type hypertension, stroke and diabetes in China: Opportunities for primary prevention. J. Diabetes 2016, 8, 38–40. [CrossRef] [PubMed]
16. McCully, K.S. Homocysteine, vitamins, and vascular disease prevention. Homocysteine, vitamins, and vascular disease prevention. Am. J. Clin. Nutr. 2007, 86, 1563–1568.
17. Asplund, K.; Karvanen, J.; Giampaoli, S.; Jousilahti, P.; Niemelä, M.; Broda, G.; Cesana, G.; Dallongeville, J.; Ducimetriere, P.; Evans, A. et al. Relative Risks for Stroke by Age, Sex, and Population Based on Follow-Up of 18 European Populations in the MORGAM Project. Stroke 2009, 40, 2319–2326. [CrossRef] [PubMed]
18. Pinho, J.; Braga, C.G.; Rocha, S.; Santos, A.F.; Gomes, A.; Cabreiro, A.; Magalhães, S.; Ferreira, C. Atrial ectopic activity in cryptogenic ischemic stroke and TIA: A risk factor for recurrence. Natl. Stroke Assoc. 2015, 24, 507–510. [CrossRef] [PubMed]
19. Chen, P.; Ma, Z.Y.; Shi, L.N. Risk factors of recurrence in patients with ischemic stroke in Ningxia area of China. J. Ningxia Med. Coll. 2014, 36, 401–404.
20. Wang, X.; Shi, J.X. Study on the related factors of recurrence in patients with ischemic stroke. Chin. J. Postgrad. Med. 2006, 13, 44–45.
21. Modrego, P.J.; Pina, M.A.; Fraj, M.M.; Llorens, N. Type, causes, and prognosis of stroke recurrence in the province of Teruel, Spain. A 5-year analysis. Neurol. Sci. 2000, 21, 355–360. [CrossRef] [PubMed]
22. Hillen, T.; Coshall, C.; Tilling, K.; Rudd, A.G.; McGovern, R.; Wolfe, C.D.; South London Stroke Register. Cause of stroke recurrence is multifactorial: Patterns, risk factors, and outcomes of stroke recurrence in the South London stroke register. Stroke 2003, 34, 1457–1463. [CrossRef] [PubMed]
23. Hankey, G.J.; Jamrozik, K.; Broadhurst, R.J.; Forbes, S.; Burvill, P.W.; Anderson, C.S.; Stewart-Wynne, E.G. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998, 29, 2491–2500. [CrossRef] [PubMed]
24. Hankey, G.J.; Jamrozik, K.; Broadhurst, R.J.; Forbes, S.; Burvill, P.W.; Anderson, C.S.; Stewart-Wynne, E.G. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. J. Stroke Cerebrovasc. Dis. 2015, 24, 1961–1968.
25. Han, J.H.; Ho, S.S.; Lam, W.W.; Wong, K.S. Total cerebral blood flow estimated by color velocity imaging quantification ultrasound: A predictor for recurrent stroke. J. Cereb. Blood Flow Metab. 2007, 27, 850–856. [CrossRef] [PubMed]
26. Mather, K.J.; Steinberg, H.O.; Baron, A.D. Insulin resistance in the vasculature. J. Clin. Investig. 2013, 123, 1003–1004. [CrossRef] [PubMed]
27. Schoch, H.J.; Fischer, S.; Marti, H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leak age in the brain. Brain 2002, 125, 2549–2557. [CrossRef] [PubMed]
28. Capes, S.E.; Hunt, D.; Malmberg, K.; Pathak, P.; Gerstein, H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 2001, 32, 2426–2432. [CrossRef] [PubMed]
29. Venugopal, S.K.; Devaraj, S.; Jialal, I. Effect of C-reactive protein on vascular cells: Evidence for a proinflammatory, proatherogenic role. Curr. Opin. Nephrol. Hypertens. 2005, 14, 33–37. [CrossRef] [PubMed]
30. Di Napoli, M.; Schwaninger, M.; Cappelli, R.; Ceccarelli, E.; di Gianfilippo, G.; Donati, C.; Emsley, H.C.; Forconi, S.; Hopkins, S.J.; Masotti, L. et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: A statement for health care professionals from the CRP Pooling Project members. Stroke 2005, 36, 1316–1329. [CrossRef] [PubMed]
31. Curb, J.D.; Abbott, R.D.; Rodriguez, B.L.; Sakkinen, P.; Popper, J.S.; Yano, K.; Tracy, R.P. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003, 107, 2016–2020. [CrossRef] [PubMed]
32. Elkind, M.S.; Luna, J.M.; Moon, Y.P.; Liu, K.M.; Spitalnik, S.L.; Paik, M.C.; Sacco, R.L. High-sensitivity C-reactive protein predicts mortality but not stroke in a multi-ethnic cohort: The Northern Manhattan Study. Neurology 2009, 73, 1300–1307. [CrossRef] [PubMed]
33. Gussekloo, J.; Schaap, M.C.; Frölich, M.; Blauw, G.J.; Westendorp, R.G. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1047–1451. [CrossRef] [PubMed]
34. Di Napoli, M.; Papa, F.; Bocola, V. Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke. Stroke 2001, 32, 133–138. [CrossRef] [PubMed]
35. Elkind, M.S.; Luna, J.M.; McClure, L.A.; Zhang, Y.; Coffey, C.S.; Roldan, A.; Del Brutto, O.H.; Pretell, E.J.; Pettigrew, L.C.; Meyer, B.C. et al. C-reactive protein as a prognostic marker after lacunar stroke: Levels of inflammatory markers in the treatment of stroke study. Stroke 2014, 45, 707–716. [CrossRef] [PubMed]
36. Wakugawa, Y.; Kiyohara, Y.; Tanizaki, Y.; Kubo, M.; Ninomiya, T.; Hata, J.; Doi, Y.; Okubo, K.; Oishi, Y.; Shikata, K. et al. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: The Hisayama Study. Stroke 2006, 37, 27–32. [CrossRef] [PubMed]
37. Song, I.U.; Kim, Y.D.; Kim, J.S.; Lee, K.S.; Chung, S.W. Can high-sensitivity C-reactive protein and plasma homocysteine levels independently predict the prognosis of patients with functional disability after first-ever ischemic stroke? Eur. Neurol. 2010, 64, 304–310. [CrossRef] [PubMed]
38. Lorenz, M.W.; Karbstein, P.; Markus, H.S.; Sitzer, M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: The carotid atherosclerosis progression study. Stroke 2007, 38, 1774–1779. [CrossRef] [PubMed]
39. Chapman, C.M.; Beilby, J.P.; McQuillan, B.M.; Thompson, P.L.; Hung, J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 2004, 35, 1619–1624. [CrossRef] [PubMed]
40. Kharbanda, R.K.; Walton, B.; Allen, M.; Klein, N.; Hingorani, A.D.; MacAllister, R.J.; Vallance, P. Prevention of inflammation-induced endothelial dysfunction: A novel vasculo-protective action of aspirin. Circulation 2002, 105, 2600–2604. [CrossRef] [PubMed]
41. Albert, M.A.; Ridker, P.M. The role of C-reactive protein in cardiovascular disease risk. Curr. Cardiol. Rep. 1999, 1, 99–104. [CrossRef] [PubMed]
42. Sen, U.; Mishra, P.K.; Tyagi, N.; Tyagi, S.C. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem. Biophys. 2010, 57, 49–58. [CrossRef] [PubMed]
43. Zhang, W.; Sun, K.; Chen, J.; Liao, Y.; Qin, Q.; Ma, A.; Wang, D.; Zhu, Z.; Wang, Y.; Hui, R. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clin. Sci. (Lond.) 2009, 118, 187–194. [CrossRef] [PubMed]
44. Xu, G.; Liu, X.; Wu, W.; Zhang, R.; Yin, Q. Recurrence after ischemic stroke in Chinese patients: Impact of uncontrolled modifiable risk factors. Cerebrovasc. Dis. 2007, 23, 117–120. [CrossRef] [PubMed]
45. Aiyagari, V.; Badruddin, A. Management of hypertension in acute stroke. Expert Rev. Cardiovasc. Ther. 2009, 7, 637–646. [CrossRef] [PubMed]
46. Saposnik, G.; Ray, J.G.; Sheridan, P.; McQueen, M.; Lonn, E.; Heart Outcomes Prevention Evaluation 2 Investigators. Homocysteine-lowering therapy and stroke risk, severity, and disability: Additional findings from the HOPE 2 trial. Stroke 2009, 40, 1365–1372. [CrossRef] [PubMed]
47. Graham, I.M.; Daly, L.E.; Refsum, H.M.; Robinson, K.; Brattström, L.E.; Ueland, P.M.; Palma-Reis, R.J.; Boers, G.H.; Sheahan, R.G.; Israelsson, B. et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J. Am. Med. Assoc. 1997, 277, 1775–1781. [CrossRef]
48. Mi, G.Q.; Fu, Y.; Mao, J.J.; Xu, M.Z. Relationship between “H type” hypertension and senile recurrent cerebral infarction. Chin. J. Gerontol. 2011, 31, 1859–1860.
49. Jacob, R.A.; Wu, M.M.; Henning, S.M.; Swendseid, M.E. Homocysteine increases as folate decreases in plasma of healthy men during short-term dietary folate and methyl group restriction. J. Nutr. 1994, 124, 1072–1080. [PubMed]
50. Yang, H.T.; Lee, M.; Hong, K.S.; Ovbiagele, B.; Saver, J.L. Efficacy of folic acid supplementation in cardiovascular disease prevention: An updated meta-analysis of randomized controlled trials. Eur. J. Intern. Med. 2012, 23, 745–754. [CrossRef] [PubMed]